Ironwood Pharmaceuticals Inc (IRWD)
6.30
+0.24
(+3.96%)
USD |
NASDAQ |
May 31, 16:00
6.31
+0.01
(+0.16%)
After-Hours: 20:00
Ironwood Pharmaceuticals Revenue (Annual): 442.74M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 442.74M |
| December 31, 2022 | 410.60M |
| December 31, 2021 | 413.75M |
| December 31, 2020 | 389.52M |
| December 31, 2019 | 428.41M |
| December 31, 2018 | 346.64M |
| December 31, 2017 | 298.28M |
| December 31, 2016 | 273.96M |
| December 31, 2015 | 149.56M |
| Date | Value |
|---|---|
| December 31, 2014 | 76.44M |
| December 31, 2013 | 22.88M |
| December 31, 2012 | 150.24M |
| December 31, 2011 | 65.87M |
| December 31, 2010 | 43.86M |
| December 31, 2009 | 34.32M |
| December 31, 2008 | 22.22M |
| December 31, 2007 | 10.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
389.52M
Minimum
2020
442.74M
Maximum
2023
417.00M
Average
413.75M
Median
2021
Revenue (Annual) Benchmarks
| Amicus Therapeutics Inc | 399.36M |
| Insmed Inc | 305.21M |
| Altimmune Inc | 0.426M |
| Cassava Sciences Inc | -- |
| InfuSystems Holdings Inc | 125.78M |